Co-led Oricell Therapeutics' $110M pre-IPO financing round to accelerate global CAR-T development.
Oricell Therapeutics is a clinical-stage biotech company focused on innovating effective and affordable cell therapies for cancer patients, particularly through CAR-T technology
Oricell Therapeutics is a clinical-stage biotech company focused on innovating effective and affordable cell therapies for cancer patients, particularly through CAR-T technology. The company aims to address unmet clinical needs in oncology, developing therapies for liver cancer, multiple myeloma, and other malignancies.